Tabula Rasa HealthCare (TRHC) Misses Q1 EPS by 2c, Beat on Revenue; Reaffirms FY17 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Tabula Rasa Healthcare (TRHC) PT Lowered to $16 at Stifel on 1Q EPS Miss; 'Unrelenting Healthcare Trends'
May 2, 2017 7:25 AM EDTStifel lowered its price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $16.00 (from $19.00) while maintaining a Buy rating, following the company's first quarter earnings report.
Analyst Thomas Carroll notes the company delivered mixed first quarter results, offering EPS below consensus and revenues above the Street's... More
